Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Opinion in Oncology|October 1, 1991
Chemotherapy and combined modality treatment in Hodgkin's diseaseE R Gaynor, R I FisherSeminars in Oncology|October 1, 1991
Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphomaE R Gaynor, R I FisherOncology (Williston Park, N.Y.)|December 1, 1995
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?E R Gaynor, R I FisherDisease-A-Month : DM|September 1, 1989
Recent advances in the management of non-Hodgkin's lymphomasE R Gaynor, R I FisherSeminars in Oncology|April 1, 1992
Bleomycin in non-Hodgkin's lymphomaR A Bayer, E R Gaynor, R I FisherJournal of Computer Assisted Tomography|July 1, 1997
Colosplenic fistula in a patient treated with interleukin-2 for malignant melanomaE S Chun, T C Demos, E R GaynorJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institutionE R Gaynor, J E Ultmann, H M Golomb, et al.Cancer|August 1, 1985
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemiaJ N Winter, D Variakojis, E R Gaynor, et al.Investigational New Drugs|April 1, 1992
Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group studyS A Taylor, P Goodman, E D Crawford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Long-term survival of patients with localized diffuse histiocytic lymphomaE E Vokes, J E Ultmann, H M Golomb, et al.Pageof 3